Ad5/3-E2F-d24-vIL2 virus treatment stimulates high granzyme B production by CD4+ T, CD8+ T, and NK cells in ovarian cancer tumors treated with TILs therapy. This evidence concerns the gene GZMB and ovarian carcinoma.